New Global Consensus on RBD Treatment: What You Need to Know

 
 
 

Explore the latest consensus on managing RBD, led by NAPS Investigator Dr. Aleksandar Videnovic and the International RBD study group. This important work highlights effective treatment strategies, including safety measures and patient-centered considerations for therapies like clonazepam, melatonin, rivastigmine, and pramipexole. Dive into the efficacy, dosing, and future directions for advancing care in REM Sleep Behavior Disorder (RBD).

 
Previous
Previous

Unlocking Brain Health: New Study Explores Breakthrough MRI Technique for Early Parkinson’s Detection

Next
Next

2025 International RBD Study Group Meeting